$57M sweet spot round size
Most of their 15 investments are in rounds between $36M and $80M
2004
Neurona Therapeutics raised $42M on June 22, 2021
Investors: UCB Ventures, Ironfire Capital LLC, The Column Group and Sphera Fund
Field Trip Health raised $76M on March 17, 2021
Investors: Soleus Capital Management, L.P., Avidity Partners, Pura Vida Investments, Jennison Associates LLC and Sphera Fund
Galecto, Inc. raised $64M on September 25, 2020
Investors: Maverick Ventures, Ysios Capital, Novo Holdings, OrbiMed Advisors, Sunstone Life Science Ventures, Seventure Partners, Soleus Capital Management, L.P. and Sphera Fund
Undisclosed raised $50M on July 2, 2020
Investors: AFCON SWS, Halman Aldubi Investment House and Sphera Fund
C4 Therapeutics, Inc. raised undisclosed on June 16, 2020
Investors: Nextech Invest, みずほ証券プリンシパルインベストメント(株), RTW Investments, LP, Perceptive Advisors, Logos Global Management, LP, RA Capital Management, L.P., Taiwania Capital, T. Rowe Price and Sphera Fund
Immatics Biotechnologies raised $104M on March 17, 2020
Investors: Wellington Partners, Perceptive Advisors, RTW Investments, LP, Redmile Group and Sphera Fund
Passage Bio raised $110M on September 4, 2019
Investors: Lilly Asia Ventures, Versant Ventures, OrbiMed Advisors, Frazier Healthcare Partners, New Leaf Venture Partners, Vivo Capital and Sphera Fund
Oncorus, Inc. raised $80M on August 21, 2019
Investors: Shinhan Bank, UTC Investment Co.,Ltd., Perceptive Advisors, MPM Capital, QUAD Investment Management, Surveyor Capital, IMM Investment Corp. and Sphera Fund
Stoke Therapeutics raised $90M on October 23, 2018
Investors: RA Capital Management, L.P., Perceptive Advisors, ATP (Apple Tree Partners), Redmile Group, RTW Investments, LP and Sphera Fund
Galmed Pharmaceuticals Ltd. raised $12M on January 3, 2018
Investors: Meitav Dash and Sphera Fund